- Home
- CODX vs BMRA Comparison
CODX vs BMRA Comparison
Compare CODX & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- BMRA
- Stock Information
- Founded
- CODX 2013
- BMRA 1971
- Country
- CODX United States
- BMRA United States
- Employees
- CODX N/A
- BMRA N/A
- Industry
- CODX Medical/Dental Instruments
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CODX Health Care
- BMRA Health Care
- Exchange
- CODX Nasdaq
- BMRA Nasdaq
- Market Cap
- CODX 9.8M
- BMRA 8.1M
- IPO Year
- CODX 2017
- BMRA N/A
- Fundamental
- Price
- CODX $0.26
- BMRA $3.03
- Analyst Decision
- CODX Buy
- BMRA
- Analyst Count
- CODX 2
- BMRA 0
- Target Price
- CODX $5.50
- BMRA N/A
- AVG Volume (30 Days)
- CODX 825.6K
- BMRA 43.5K
- Earning Date
- CODX 08-14-2025
- BMRA 08-27-2025
- Dividend Yield
- CODX N/A
- BMRA N/A
- EPS Growth
- CODX N/A
- BMRA N/A
- EPS
- CODX N/A
- BMRA N/A
- Revenue
- CODX $3,497,583.00
- BMRA $5,678,000.00
- Revenue This Year
- CODX N/A
- BMRA N/A
- Revenue Next Year
- CODX $42.11
- BMRA N/A
- P/E Ratio
- CODX N/A
- BMRA N/A
- Revenue Growth
- CODX N/A
- BMRA 5.01
- 52 Week Low
- CODX $0.23
- BMRA $2.08
- 52 Week High
- CODX $2.23
- BMRA $10.16
- Technical
- Relative Strength Index (RSI)
- CODX 47.45
- BMRA 38.90
- Support Level
- CODX $0.25
- BMRA $3.07
- Resistance Level
- CODX $0.27
- BMRA $3.20
- Average True Range (ATR)
- CODX 0.02
- BMRA 0.22
- MACD
- CODX -0.00
- BMRA -0.06
- Stochastic Oscillator
- CODX 45.27
- BMRA 0.00
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.